ストックスクリーナーアプリを入手
3.87
5.45%
0.20
アフターアワーズ：
3.85
-0.02
-0.52%
前日終値:
$3.67
開ける：
$3.67
24時間の取引高:
378.60K
Relative Volume:
0.60
時価総額：
$103.02M
収益：
$50.14M
当期純損益:
$-35.38M
株価収益率:
-2.7643
EPS:
-1.4
ネットキャッシュフロー:
$-39.46M
1週間 パフォーマンス:
-2.52%
1か月 パフォーマンス:
-24.27%
6か月 パフォーマンス:
-60.06%
1年 パフォーマンス:
-61.68%
1日の値動き範囲:
$3.669
$4.02
1週間の範囲:
$3.64
$4.02
52週間の値動き範囲:
$3.60
$14.16
Avita Medical Inc Stock (RCEL) Company Profile
RCEL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
3.87 | 99.16M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.88B | 1.34B | 577.90M | 2.3455 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-08 | ダウングレード | BTIG Research | Neutral → Sell |
| 2024-12-24 | 開始されました | D. Boral Capital | Buy |
| 2024-04-11 | ダウングレード | BTIG Research | Buy → Neutral |
| 2023-06-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-03-02 | 開始されました | Piper Sandler | Overweight |
| 2020-08-27 | 開始されました | BofA Securities | Buy |
| 2020-04-21 | 開始されました | Oppenheimer | Outperform |
| 2020-03-03 | 開始されました | BTIG Research | Buy |
すべてを表示
Avita Medical Inc (RCEL) 最新ニュース
Using AI based signals to follow AVITA Medical Inc.Market Movers & Free Real-Time Volume Trigger Notifications - newser.com
Is AVITA Medical Inc. stock a top pick in earnings seasonTrade Volume Summary & Safe Capital Investment Plans - newser.com
AVITA Medical, Inc. (RCEL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Will AVITA Medical Inc. stock benefit from commodity pricesJuly 2025 Action & Fast Entry and Exit Trade Plans - newser.com
Why AVITA Medical Inc. stock remains a top recommendationJuly 2025 Update & Accurate Technical Buy Alerts - newser.com
Leading vs lagging indicators on AVITA Medical Inc. performanceEntry Point & Community Trade Idea Sharing Platform - newser.com
Published on: 2025-11-01 12:29:56 - newser.com
Is AVITA Medical Inc. stock attractive for ETFs2025 Macro Impact & Risk Adjusted Buy/Sell Alerts - newser.com
How analysts rate AVITA Medical Inc. stock todayMarket Risk Report & Daily Growth Stock Tips - newser.com
Avita Medical (RCEL) to Release Quarterly Earnings on Thursday - MarketBeat
Historical volatility pattern of AVITA Medical Inc. visualizedQuarterly Profit Report & Real-Time Volume Analysis Alerts - newser.com
Can AVITA Medical Inc. stock hit analyst price targetsRisk Management & Free High Accuracy Swing Entry Alerts - newser.com
Is it too late to sell AVITA Medical Inc.IPO Watch & Safe Capital Growth Trade Ideas - newser.com
How AVITA Medical Inc. stock performs in weak economyJuly 2025 Retail & Weekly Momentum Picks - newser.com
Will AVITA Medical Inc. stock outperform Nasdaq index2025 Short Interest & Growth Oriented Trading Recommendations - newser.com
Is AVITA Medical Inc. stock a buy for dividend growth2025 Valuation Update & Fast Exit and Entry Trade Guides - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages AVITA Medical, Inc. (RCEL) Investors to Inquire about Securities Investigation - ACCESS Newswire
How risky is AVITA Medical Inc. stock now2025 Market Outlook & AI Driven Stock Movement Reports - newser.com
How AVITA Medical Inc. stock performs during Fed tightening cyclesWeekly Market Summary & Weekly High Potential Stock Alerts - newser.com
What analysts say about AVITA Medical Inc stockEarnings Volatility Patterns & High Return Portfolio Growth - earlytimes.in
AVITA Medical to Announce Third Quarter 2025 Financial Results - Investing News Network
AVITA Medical (NASDAQ: RCEL) sets Nov. 6, 2025 call to discuss third-quarter results - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against AVITA Medical, Inc. (RCEL) And Encourages Investors to Reach Out - ACCESS Newswire
Rosen Law Firm Encourages AVITA Medical, Inc. Investors to Inquire About Securities Class Action Investigation – RCEL - The AI Journal
Rosen Law Firm Encourages AVITA Medical, Inc. Investors to Inquire About Securities Class Action Investigation - FinancialContent
Avita Medical (RCEL) Gains Support for Recell in Australia - GuruFocus
AVITA Medical Welcomes Support for RECELL® in Burns in Australia - Investing News Network
AVITA Medical (NASDAQ: RCEL) MSAC recommends RECELL on MBS for severe burns ≥20% TBSA - Stock Titan
Is AVITA Medical Inc. stock attractive for income investors2025 Price Momentum & Smart Investment Allocation Tips - newser.com
Avita Medical Inc (RCEL) 財務データ
収益
当期純利益
現金流量
EPS
0.34%
14.63%
大文字化:
|
ボリューム (24 時間):